ANGIODYNAMICS INC Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q2 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Angiodynamics Inc quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q2 2012 to Q2 2024.
  • Angiodynamics Inc Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending May 31, 2024 was $28.2M, a 30.2% decline year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $28.2M -$12.2M -30.2% May 31, 2024 10-K 2024-07-25
Q2 2023 $40.5M -$299K -0.73% May 31, 2023 10-K 2024-07-25
Q2 2022 $40.8M +$9.2M +29.1% May 31, 2022 10-K 2023-08-03
Q2 2021 $31.6M +$4.87M +18.2% May 31, 2021 10-K 2022-07-22
Q2 2020 $26.7M +$7.74M +40.8% May 31, 2020 10-K 2021-07-27
Q2 2019 $19M -$14.9M -44.1% May 31, 2019 10-K 2020-08-10
Q2 2018 $33.9M -$22.1M -39.5% May 31, 2018 10-K 2019-07-25
Q2 2017 $56M +$3.38M +6.43% May 31, 2017 10-K 2018-07-23
Q2 2016 $52.6M +$568K +1.09% May 31, 2016 10-K 2017-08-04
Q2 2015 $52M +$3.28M +6.72% May 31, 2015 10-K 2016-08-01
Q2 2014 $48.7M +$1.23M +2.6% May 31, 2014 10-K 2015-08-10
Q2 2013 $47.5M +$1.81M +3.96% May 31, 2013 10-K/A 2015-01-12
Q2 2012 $45.7M May 31, 2012 10-K 2013-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.